Biotech · Private company · College Station, TX, US
Astero Erado Inc
Track this companyFree. Adds Astero Erado Inc to your Dealase workspace and tells you when its record changes.
Clinical trials0None registered
Pipeline programs0None found yet
Disclosed deals0None found yet
Cash runwayNot availablePrivate: no SEC financials
NIH awards6
- Severe Autoantibody-Mediated Autoimmune Disease: A New Treatment ApproachFiscal year 2026 · $306.4KNIH RePORTER 1R43AI197270-01 · fetched Nov 12, 2026
- Novel approaches for the treatment of autoimmune diseaseFiscal year 2026 · $1MNIH RePORTER 5R44AI174502-03 · fetched Nov 12, 2026
- Novel approaches for the treatment of autoimmune diseaseFiscal year 2025 · $1MNIH RePORTER 2R44AI174502-02A1 · fetched Nov 12, 2026
- Depleting autoantibodies for the treatment of autoimmunityFiscal year 2025 · $863.2KNIH RePORTER 5R44AI170180-04 · fetched Nov 12, 2026
- Novel treatments for Autoimmune DiseaseFiscal year 2024 · $293.5KNIH RePORTER 5R43AI179252-02 · fetched Nov 12, 2026
- Depleting autoantibodies for the treatment of autoimmunityFiscal year 2024 · $1MNIH RePORTER 5R44AI170180-03 · fetched Nov 12, 2026